Medpace Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	1,886	1,460	1,142	925.93	860.97	704.59	436.15	421.58	359.06
Revenue Growth (YoY)	29.17%	27.80%	23.38%	7.54%	22.19%	61.55%	3.46%	17.41%	-
Cost of Revenue	1,361	1,028	814.22	647.2	615.27	489.06	261.46	249.47	202.67
Gross Profit	524.51	432.44	328.16	278.73	245.7	215.53	174.69	172.11	156.39
Selling, General & Admin	161.35	131.4	108.42	92.16	95.25	75.68	63.36	61.51	57
Other Operating Expenses	26.33	22.34	21.12	19.53	23.19	38.8	46.47	58.11	78.83
Operating Expenses	187.68	153.74	129.54	111.68	118.43	114.48	109.83	119.62	135.83
Operating Income	336.83	278.7	198.62	167.04	127.26	101.05	64.86	52.49	20.56
Interest Expense / Income	0.49	2.91	0.11	-0.31	1.57	8.16	7.56	19.38	27.26
Other Expense / Income	0.66	-7.07	-3.34	-1.18	0.86	-1.06	0.35	11.15	1.13
Pretax Income	335.68	282.86	201.85	168.53	124.83	93.95	56.95	21.96	-7.83
Income Tax	52.87	37.49	20	23.15	24.39	20.77	17.82	8.53	0.84
Net Income	282.81	245.37	181.85	145.38	100.44	73.19	39.12	13.43	-8.67
Net Income Growth	15.26%	34.93%	25.08%	44.74%	37.25%	87.07%	191.41%	-	-
Shares Outstanding (Basic)	31	32	36	36	36	36	39	36	31
Shares Outstanding (Diluted)	32	34	38	38	38	37	40	36	31
Shares Change	-5.43%	-10.68%	-0.03%	0.35%	1.80%	-7.35%	9.66%	15.90%	-
EPS (Basic)	9.20	7.57	5.06	4.07	2.79	2.05	1.00	0.38	-0.28
EPS (Diluted)	8.88	7.28	4.81	3.84	2.67	1.97	0.98	0.37	-0.28
EPS Growth	21.98%	51.35%	25.26%	43.82%	35.53%	101.02%	164.86%	-	-
Free Cash Flow	396.73	351.17	235.06	227.34	183.96	140.56	85.66	78.2	79.41
Free Cash Flow Per Share	12.91	10.84	6.55	6.38	5.13	3.95	2.19	2.19	2.53
Gross Margin	27.81%	29.62%	28.73%	30.10%	28.54%	30.59%	40.05%	40.83%	43.56%
Operating Margin	17.86%	19.09%	17.39%	18.04%	14.78%	14.34%	14.87%	12.45%	5.73%
Profit Margin	15.00%	16.81%	15.92%	15.70%	11.67%	10.39%	8.97%	3.18%	-2.42%
Free Cash Flow Margin	21.04%	24.05%	20.58%	24.55%	21.37%	19.95%	19.64%	18.55%	22.11%
Effective Tax Rate	15.75%	13.25%	9.91%	13.74%	19.54%	22.10%	31.30%	38.86%	-
EBITDA	382.14	326.12	239.36	201.68	159.54	140.91	110.98	99.46	88.95
EBITDA Margin	20.26%	22.34%	20.95%	21.78%	18.53%	20.00%	25.44%	23.59%	24.77%
Depreciation & Amortization	45.97	40.36	37.41	33.45	33.14	38.8	46.47	58.11	69.52
EBIT	336.17	285.77	201.96	168.23	126.4	102.11	64.5	41.34	19.43
EBIT Margin	17.83%	19.57%	17.68%	18.17%	14.68%	14.49%	14.79%	9.81%	5.41%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).